Cost-effectiveness of denosumab for high-risk postmenopausal women with osteoporosis in Thailand-Reference-Cited by-同舟云学术

Cost-effectiveness of denosumab for high-risk postmenopausal women with osteoporosis in Thailand

Published:2020-02-28 Issue:7 Volume:23 Page:776-785
ISSN:1369-6998
Container-title:Journal of Medical Economics
language:en
Short-container-title:Journal of Medical Economics

Author:

Pongchaiyakul Chatlert¹,Nanagara Ratanavadee¹,Songpatanasilp Thawee²,Unnanuntana Aasis³

Affiliation:

1. Department of Medicine, Faculty of Medicine, Khon Kaen University, Thailand;

2. Department of Orthopaedics, Faculty of Medicine, Phramongkutklao Hospital, Thailand;

3. Department of Orthopedic Surgery, Faculty of Medicine Siriraj Hospital, Mahidol University, Thailand

Publisher

Informa UK Limited

Subject

Health Policy

Link

https://www.tandfonline.com/doi/pdf/10.1080/13696998.2020.1730381

Reference55 articles.

1. Bone geometry and skeletal fragility

2. Bone Remodeling Increases Substantially in the Years After Menopause and Remains Increased in Older Osteoporosis Patients

3. Prevalence of osteopenia and osteoporosis in Thai women

4. International Osteoporosis Foundation. Thailand: Regional Asia Audit. 2019 [cited 2019 Feb 4]; Available from: https://www.iofbonehealth.org/sites/default/files/PDFs/Audit%20Asia/Asian_regional_audit_Thailand.pdf.

5. The Incidence of Hip Fracture in Four Asian Countries: The Asian Osteoporosis Study (AOS)

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of Bone Density Changes Before and After One Year of Denosumab (Prolia) Administration in Osteoporosis Patients;Annals of Military and Health Sciences Research;2024-03-12

2. Cost‐effectiveness analysis of sintilimab plus IBI305 versus sorafenib for unresectable hepatic cell carcinoma in China;Cancer Medicine;2023-07

3. Current issues in evaluation and management of osteoporosis in Thailand;Osteoporosis and Sarcopenia;2023-06

4. Cost-Effectiveness Analysis of Sintilimab Combined with Chemotherapy Versus Chemotherapy Alone as the First-Line Treatment for Advanced Esophageal Cancer;Frontiers in Pharmacology;2022-11-28

5. Cost-effectiveness of Denosumab for the Treatment of Postmenopausal Osteoporosis in Malaysia;Osteoporosis International;2022-05-31